Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk
Nutrients · 2023
DOI: 10.3390/nu15092207 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2023. Verfasst von Metehan Ozen und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye. Hauptthemen laut MEDLINE: Limosilactobacillus fermentum, Probiotics. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HiPP GmbH & Co. Vertrieb KG.
Abstract (Originalsprache)
Breastfeeding provides the ideal nutrition for infants. Human milk contains a plethora of functional ingredients which foster the development of the immune system. The human milk microbiota predominantly contributes to this protective effect. This is mediated by various mechanisms, such as an antimicrobial effect, pathogen exclusion and barrier integrity, beneficial effects on the gastrointestinal microbiota, vitamin synthesis, immunity enhancement, secreted probiotic factors, and postbiotic mechanisms. Therefore, human milk is a good source for isolating probiotics for infants who cannot be exclusively breastfed. One such probiotic which was isolated from human milk is Limosilactobacillus fermentum CECT5716. In this review, we give an overview of available interventional studies using Limosilactobacillus fermentum CECT5716 and summarise preclinical trials in several animal models of different pathologies, which have given first insights into its mechanisms of action. We present several randomised clinical studies, which have been conducted to investigate the clinical efficacy of the Limosilactobacillus fermentum CECT5716 strain in supporting the host’s health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Türkiye.
- Department of Paediatric Chronic Diseases, Nantes University Hospital, 44000 Nantes, France.
- HiPP GmbH & Co. Vertrieb KG, 85276 Pfaffenhofen, Germany.
ORCID-Profile: Metehan Ozen
Förderung
- HiPP GmbH & Co. Vertrieb KG
Zitieren
APA
Ozen, M., Piloquet, H., & Schaubeck, M. (2023). Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. Nutrients. https://doi.org/10.3390/nu15092207
Vancouver
Ozen M, Piloquet H, Schaubeck M. Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk. Nutrients. 2023. doi:10.3390/nu15092207
BibTeX
@article{Ozen2023,
author = {Ozen, Metehan and Piloquet, Hugues and Schaubeck, Monika},
title = {Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15092207}
}
EUVIMED